HAP Trading’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-27,800
Closed -$494K 1613
2019
Q3
$494K Sell
27,800
-500
-2% -$47.5K 0.04% 315
2019
Q2
$407K Sell
28,300
-1,792,500
-98% -$170M 0.03% 372
2019
Q1
$6.05M Buy
1,820,800
+1,610,800
+767% +$141M 0.54% 42
2018
Q4
$54K Sell
210,000
-66,000
-24% -$4.87M ﹤0.01% 740
2018
Q3
$197K Buy
276,000
+6,400
+2% +$566K 0.01% 454
2018
Q2
$223K Buy
269,600
+60,900
+29% +$5.06M 0.01% 445
2018
Q1
$854K Buy
208,700
+189,200
+970% +$18.2M 0.04% 246
2017
Q4
$36K Buy
19,500
+5,700
+41% +$643K ﹤0.01% 712
2017
Q3
$120K Sell
13,800
-9,000
-39% -$1.23M 0.01% 555
2017
Q2
$98K Sell
22,800
-11,700
-34% -$1.43M 0.01% 597
2017
Q1
$180K Buy
34,500
+14,000
+68% +$1.68M 0.01% 495
2016
Q4
$237K Buy
20,500
+6,600
+47% +$735K 0.01% 442
2016
Q3
$21K Sell
13,900
-14,900
-52% -$1.61M ﹤0.01% 860
2016
Q2
$46K Buy
28,800
+15,800
+122% +$1.63M ﹤0.01% 617
2016
Q1
$37K Buy
+13,000
New +$1.34M ﹤0.01% 568
2015
Q4
Sell
-27,900
Closed -$24K 1279
2015
Q3
$24K Buy
27,900
+9,400
+51% +$1.17M ﹤0.01% 796
2015
Q2
$15K Sell
18,500
-22,200
-55% -$2.54M ﹤0.01% 815
2015
Q1
$44K Buy
40,700
+8,800
+28% +$1.05M ﹤0.01% 634
2014
Q4
$1.1M Buy
31,900
+5,300
+20% +$559K 0.04% 303
2014
Q3
$680K Sell
26,600
-1,200
-4% -$108K 0.03% 413
2014
Q2
$480K Buy
27,800
+1,600
+6% +$122K 0.02% 453
2014
Q1
$217K Sell
26,200
-18,400
-41% -$1.46M 0.01% 601
2013
Q4
$1.22M Buy
44,600
+400
+0.9% +$31.7K 0.04% 379
2013
Q3
$978K Buy
+44,200
New +$3.1M 0.03% 375

Other funds holding CELG

HAP Trading's CELG Position: Q1 2019 in Review

HAP Trading sold out of Celgene Corp (CELG) in Q1 2019, closing a stake of 15,393 shares — an estimated $1.35M sold.

HAP Trading first reported a position in CELG in Q4 2017 and held it in 3 quarters. The position peaked at $3.81M in Q1 2018. 1,389 funds tracked by Wall St. Rank hold CELG as of Q1 2019.

  • HAP Trading reported no remaining Celgene Corp position as of Q1 2019 after selling out during the quarter.
  • HAP Trading sold 15,393 Celgene Corp shares in Q1 2019, an estimated $1.35M.
  • HAP Trading first reported a position in Celgene Corp in Q4 2017 and held it in 3 quarters.
  • HAP Trading's Celgene Corp position peaked at $3.81M in Q1 2018.
  • 1,389 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2019.

Based on HAP Trading's 13F filing for Q1 2019, filed 10 May 2019.